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Aging is accompanied by various functional modifications determined by their environment, lifestyle, nutrition, and genetics.
Based on these factors, it is essential to verify the vitamin deficiency in the elderly population. Hypovitaminosis D is commonly
present in human aging, increasing the chances of developing noncommunicable chronic diseases. (e VDR gene TaqI
polymorphism may modify the vitamin D metabolic pathway by altering the interaction between the vitamin D receptor and the
active circulating vitamin D.(erefore, this study aimed to investigate the association between serum vitamin D and biochemical
and genetic factors, considering the TaqI polymorphism of the VDR gene, in an elderly population of the Federal District. (e
study was a descriptive, case-control, quantitative, and cross-sectional type and was conducted in two basic health units in the
administrative region of Ceilândia, Federal District, DF, Brazil, with women aged 60 years or older. Anthropometric, biochemical,
and genetic parameters (VDR TaqI polymorphism) were evaluated. (e adopted significance level was 5%, and statistical analyses
were performed using the SPSS version 20.0 program.(e study consisted of 128 participants.(emost prevalent age was from 60
to 65 years (N� 53; 41.4%). 66 elderly (51.6%) were part of the case group (hypovitaminosis D), while 62 were in the control group.
In the case group, 30.2% had grade I obesity, 77.3% were hypertensive, and 51.5% were diabetic. (e TTgenotype was present in
47% of the case group and 54.8% in the control group (p � 0.667). (ere was no association between serum vitamin D levels and
the VDR gene variant TaqI polymorphism in an elderly Brazilian population.
1. Introduction
Population aging is a growing transformation in Brazil. (is
demographic transition may be elucidated (inferred) by
changes in the mortality and the birth rates, as well as the
populations’ nutritional, economic, social, and disease
profiles [1, 2].
According to the Brazilian Institute of Geography and
Statistics (IBGE), there will be about 7 million more
women than men by 2050 in Brazil, and the elderly will
probably be represented by 76 older men per 100 older
women [3].
Aging happens with increasing age, emerging structural,
and functional changes in the body. (e observed physio-
logical changes increase over the years being discreet and
natural. Nevertheless, such changes can lead to loss of
function or disease. Biological changes may develop in
various ways depending on the individual’s genetics and
lifestyle, influenced by psychological, cultural, and social
aspects [4–6].
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Vitamin D is a group made up of four cholesterol-de-
rived molecules with a basic steroid structure and can,
therefore, be classified as a steroid hormone. It participates
in various processes in the human body, acting primarily in
the regulation of calcium homeostasis, bone formation, and
resorption and interacting as well with parathyroid, kidney,
and intestine [7–9].
Vitamin D functions as a steroid hormone and is pro-
duced mainly in the skin exposed to ultraviolet radiation or
absorbed in food. It participates in cellular processes and acts
in the body’s homeostasis, mainly in phosphocalcic meta-
bolism. Its active form 25 (OH) D levels are considered
deficient when below 20 ng/mL and insufficient when be-
tween 21 and 29 ng/mL [9–12].
For vitaminD to perform its various functions within the
body, it needs to bind to the vitamin D receptor present in
almost every cell in the body. (is receptor is located in the
cytoplasm in its free form. By binding to the active form of
vitamin D, it translocates to the nucleus where it will as-
sociate with various genes, producing diverse biological
effects [13–17].
Calcitriol acts through the vitamin D receptor. It is
produced by the VDR gene (vitamin D receptor) and is a
member of the nuclear receptor superfamily that regulates
gene transcription (71). It is located on chromosome 12
(12q13.11) and has 12 exons [18].
Among the various allelic variants identified in the VDR
gene are the TaqI and FokI polymorphisms, which are single
nucleotide polymorphisms (SNPs). (ey can modify the
vitamin D metabolic pathway by altering the interaction
between the vitamin D receptor and active circulating vi-
tamin D [19–22].
(e TaqI polymorphism (rs731236) is located in exon 9
at the 3′-UTR end (nontranslated region) of the VDR gene.
It results from a T (thymine) replacement by a C (cytosine)
nucleotide, where the ATT codon transitions to
ATC—generating a silent mutation, as both encode the
amino acid isoleucine. Nonetheless, this SNP may change
some functional characteristics of the protein [20, 23–25].
(us, this study aims to investigate the association be-
tween serum vitamin D and biochemical and genetic factors,
considering the TaqI polymorphism of the VDR gene in an
elderly population of the Federal District.
2. Materials and Methods
2.1. Research Participants. (is is a quantitative, descriptive
case-control study (case: hypovitaminosis D; and control:
vitamin D sufficiency) with cross-sectional design in older
women attending a Basic Health Unit (BHU) in the Federal
District (DF), Brazil.
(e sample was selected from older women who vol-
unteered to participate and were part of one of the Family
Health Strategy (FHS) teams from two preselected BHUs.
In total, 128 participants were selected. (e inclusion cri-
teria were that all participants should be female, aged 60 years or
over, and able to understand, verbalize, and answer the pro-
posed questions. Contrarily, participants with mental illness or
cancer undergoing treatment or who have had heart surgery in
the last six months or who are taking vitamins or dietary
supplements were excluded from the study.
(e older women signed the Informed Consent Form
(ICF) and a nursing appointment was scheduled, in which
the identification form was completed with data such as
weight and height as well as health and social-economic
factors. Additionally, the participants signed the Biological
Material Guard Term, and a venous blood collection was
performed.
(is study is approved by the Research Ethics Com-
mittee (CEP) of the Health Sciences Teaching and Research
Foundation (FEPECS) of the Federal District State De-
partment of Health (SES-DF) under the opinion number
1.355.211.
2.2. Genotype Analysis. After collection, the samples were
sent to the laboratory for biochemical and genetic
processing.
For genetic analysis, deoxyribonucleic acid (DNA) was
extracted from blood collected using Invitek’s Invisorb Spin
Blood Minikit (250) (catalog# CA10-0005, lot# 1031100300)
with an average concentration of 20 ng/μL. TaqI polymor-
phism (rs721236) was genotyped (rs721236) using the po-
lymerase chain reaction restriction on fragment length
polymorphism (PCR-RFLP) based analysis. (e primers
used were sense 5′-CAGAGCATGGACAGGGAGCAAG
-3 ′and antisense 5′-GCA ACT CCT CAT GGG CTG AGG
TCT CA -3’.
Amplification was performed using the following ther-
mocycling conditions: 95°C for 5 minutes (initial denatur-
ation), followed by 35 cycles of denaturation at 94°C for 30
seconds, then by 65˚C for 30 seconds, and succeeded by 72°C
for 30 seconds for oligonucleotide annealing. (e final ex-
tension occurred at 72°C for 10 minutes.
(e PCR product for rs731236 is a 740 bp fragment that
amplified from the exon 9 regions of the VDR gene. After its
enzymatic digestion with TaqI restriction enzyme (Jena,
Germany), the TaqI polymorphism is cleaved into three
bands of 290, 245, and 205 bp, defined as mutant t (C) allele,
while the appearance of two 490 and 245 bp fragments in-
dicates the presence of the ancestral allele T (T). (erefore,
the TT genotypes were determined as 490 and 245 bp; Tt as
490, 290, 245, and 205 bp; and tt as 290, 245, and 205 bp with
regard to the TaqI polymorphism.
2.3. Statistical Analysis. For statistical analysis, absolute and
relative frequency distribution was applied for categorical
variables and means with their standard deviation for
continuous variables—with continuous data expressed as
mean± standard error (SE). Hardy–Weinberg equilibrium
adherence to the genotypic frequency in controls was an-
alyzed by the chi-square test with a degree of freedom. (e
genotypic and allelic frequencies of the case group (hypo-
vitaminosis D) were compared to the control group by the
chi-square test in recessive and dominant models. (e as-
sociation of clinical characteristics for each genotype was
analyzed using the chi-square test and Fisher’s exact test with
a significance level of 5%.
2 Journal of Aging Research
Odds ratios (ORs) of allelic and genotypic frequencies
were also calculated, with a confidence interval (CI) of 95%.
(e statistical program used was SPSS version 20.0 (SPSS
Inc., Chicago, IL, USA).
3. Results
In this study, of the 128 elderly participants, aged 60 or over,
the hypovitaminosis D prevalence was 51.6% (66 individ-
uals): 29.7% with insufficiency and 21.9% with a deficiency
for 25(OH)D. Accordingly, the case group sample size was
66 participants, and the control group was 62.
Most of the research participants were aged between 60
and 65 years (41.4%), followed by 66 to 70 years (28.9%),
were married (45.3%), were from the Northeast region
(68,8%), and declared themselves to be brown skin color
(44.5%). Moreover, they had studied for 5 to 8 years (38.3%),
are inactive in the labor market (43%), and have the income
of one minimumwage or less (50.8%), and practiced religion
is Catholicism (68.8%). Most declared that they performed
physical activity (73.4%), regularly slept (50%), had in-
somnia (31.3%), did not smoke (89.8%), and did not use
alcoholic beverages (95.3%) (Table 1).
Some older women had preexisting illnesses prior to the
research. 78.1% had arterial hypertension, 53.9% had dia-
betes mellitus, 2.3% had fibromyalgia, and 12.5% had an
inflammatory disease. A few had more than one disease
(Table 2).
(e genotypic distribution of the TaqI polymorphism
was consistent with Hardy–Weinberg equilibrium between
the group of participants with hypovitaminosis D
(p � 0.857) and the control group (p � 0.393). Table 3
describes the genotypic distributions of the VDR gene
TaqI polymorphism associated with the case and control
groups, in which there was no statistical difference
(p � 0.677). (e homozygous ancestral genotype (TT) was
more prevalent than the other genotypes, both in the
hypovitaminosis D group (47.0%) and in the control group
(54.8%).(e ancestral allele (T) presented a more significant
presence in both groups, with 68.8% in the case group and
72.6% in the control group.
Table 4 presents the description of life habit charac-
teristics, according to the TaqI polymorphism of the
hypovitaminosis D and control groups. 82.4% of the control
group participants with the ancestral genotype (TT) prac-
ticed a physical activity compared to 64.5% in the case group.
As for the older women who presented the mutant allele
(Tt + tt), 74.3% exercised compared to 71.4% in the control
group.
In the sleep variable, 58.8% of participants in the control
group with the TT genotype had regular sleep patterns
compared to 41.9% in the case group. Likewise, 48.6% of the
participants with the Tt + tt genotype in the case group had
regular sleep patterns compared to 50% in the control group.
Of the participants who had the ancestral genotype (TT),
90.3% did not smoke compared to 94.1% in the control
group, while of the participants with mutated allele (Tt + tt),
91.4% of the case group did not smoke compared to 82.1% of
the control group. Furthermore, 100.0% of the
hypovitaminosis D group with Tt + tt genotype did not use
alcoholic beverages compared to 89.3% of the control group.
(e clinical characteristics, systemic arterial hyperten-
sion (SAH), and diabetes mellitus (DM), correlated to the
TaqI polymorphism, TT and Tt + tt genotypes, divided into
groups, showed no statistical difference, as shown in Table 5.
In the case group with the mutated allele (Tt + tt), 77.1% of
participants had SAH compared to 82.1% of the control
group. In the ancestral genotype (TT), 51.6% of the case
group had diabetes, compared to 44.1% of the control group.
For inflammatory diseases with ancestral genotype (TT),
Table 1: Sociodemographic characteristics of older women
attended at a Basic Health Unit (N� 128). Ceilândia, Braśılia, DF,
2018.
Variable Description N %
Age range
60–65 years 53 41.4
66–70 years 37 28.9
71–75 years 23 18.0
76–80 years 10 7.8






No reply 2 1.6












No reply 4 3.2
Schooling in years of study
0–4 years 48 37.5
5–8 years 49 38.3






No reply 8 6.2
Monthly income in minimum wage
≤1 salary 65 50.8
2 to 3 salaries 35 27.3
4 to 5 salaries 6 4.7
≥6 salaries 2 1.6
Without income 3 2.3







No reply 3 2.4
N: number of participants; %: percentage; M: average; SD: standard de-
viation; min: minimum;max: maximum; ±: more or less; ≥: greater or equal;
≤: less than or equal; minimum wage: referent to the year 2017 in Brazil
(nine hundred thirty-seven reais).
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Table 2: Clinical characteristics of older women who attended a Basic Health Unit (N� 128). Ceilândia, Braśılia, DF, 2018.
Variables
Groups
p OR CI25(OH)Dinsufficiency Control
N % N %
Arterial hypertension
Yes 51 77.3 49 79.0
0.806a 0.902 (0.39–2.09)No 15 22.7 13 21.0
Total 66 100.0 62 100.0
Diabetes mellitus
Yes 34 51.5 35 56.5
0.578a 0.819 (0.41–1.64)No 32 48.5 27 43.5
Total 66 100.0 62 100.0
Fibromyalgia
Yes 2 3.0 1 1.6
0.999b 0.525 (0.05–5.93)No 64 97.0 61 98.4
Total 66 100.0 62 100.0
Inflammatory diseases
Yes 10 15.2 6 9.7
0.348a 1.667 (0.57–4.90)No 56 84.8 56 90.3
Total 66 100.0 62 100.0
a: chi-square test; b: Fisher’s exact test.
Table 3: Genotypic and allelic distribution of the TaqI polymorphism associated with the hypovitaminosis D and control groups.
TaqI
Groups
p OR ICHypovitaminosis D Control
N % N %
TT 31 47.0 34 54.8
0.667 NA NATt 28 42.4 22 35.5Tt 7 10.6 6 9.7
Total 66 100.0 62 100.0
TT 31 47.0 34 54.8
0.374 0.729 (0.36–1.46)Tt + tt 35 53.0 28 45.2
Total 66 100.0 62 100.0
T 42 31.8 34 27.4
0.442 1.235 (0.72–2.12)T 90 68.2 90 72.6
Total 132 100.0 124 100.0
NA: not applicable; chi-square test.
Table 4: Distribution of life habit characteristics: physical activity, sleep, smoking, and alcoholism, according to the TaqI polymorphism of










N % N % N % N %
Physical activity
Yes 20 64.5 28 82.4 0.202 26 74.3 20 71.4 0.267
No 10 32.3 6 17.6 9 25.7 6 21.4
No reply 1 3.2 0 0 0 0 2 7.1
Sleep
Normal 13 41.9 20 58.8 0.340 17 48.6 14 50 0.454
Insomnia 11 35.5 11 32.4 12 34.3 6 21.4
Difficulty sleeping 6 19.4 3 8.8 6 17.1 7 25
No reply 1 3.2 0 0 0 0 1 3.6
Smoking
Yes 2 6.5 2 5.9 0.568 1 2.9 4 14.3 0.239
No 28 90.3 32 94.1 32 91.4 23 82.1
No reply 1 3.2 0 0 2 5.7 1 3.6
Ethics
Yes 0 0 2 5.9 0.231 0 0 2 7.1 0.140
No 30 96.8 32 94.1 35 100 25 89.3
No reply 1 3.2 0 0 0 1 3.6
Pearson’s chi-square test.
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83.9% of the participants had no disease, compared to 85.3%
of the control group.
Table 6 presents older women divided into obese/
overweight and nonobese women associated with the ge-
notypes of the TaqI polymorphism, divided into case and
control groups. Of the older women with hypovitaminosis D
and mutated allele (t), 88.2% were obese or overweight,
compared to 88.9% in the control group. Of the ones with
the ancestral genotype (TT) and part of the case group,
75.9% were obese or overweight compared to 90.6% of the
control group. None of these differences were significant.
Biochemical analyses such as measurement of total
cholesterol and fractions, liver and kidney function markers,
glucose, and glycated hemoglobin (HbA1c) were obtained
from the research participants.
Table 7 assesses the difference in means of these bio-
chemical parameters between the study groups in the different
genotypes. With regard to the ancestral genotype (TT), the
mean of glucose, HbA1c, triglycerides, HDL, aspartate
transaminase (AST), alanine transaminase (ALT), creatinine,
and urea was not significantly different. However, when
observing the total cholesterol averages (184.86mg/dL) in the
case group in relation to the control group (211.68mg/dL),
the difference was statistically significant (p � 0.012). In the
case of LDL cholesterol, the case group presented an average
of 110.55mg/dL against 130.52mg/dL in the control group,
and this variation was also statistically significant (p � 0.050).
As for the Tt + tt genotypes, the parameters of HDL
(p � 0.046) and creatinine (p � 0.039) presented statistical
differences. Nevertheless, there was no significant difference
found between mutated genotypes and the other bio-
chemical tests analyzed.
4. Discussion
(is study investigated several determinants for serum vi-
tamin D levels, as well as whether the VDR gene’s TaqI
polymorphism is associated with vitamin D deficiency and
insufficiency. Hypovitaminosis D is a significant health
problem, especially in the elderly population. (is defi-
ciency/insufficiency may be related to life habits, food,
sports, and obesity, as well as the presence of other pa-
thologies [13, 26].
(e prevalence of serum vitamin D insufficiency and
deficiency in this study was 29.7% and 21.9%, respectfully.
(e study of Laird et al. [27] corroborates our findings, and it
was performed with 5,356 participants in Ireland, in which
53.4% were women with an average age of 62.9 years. 13.1%
of the studied population had vitamin D deficiency, re-
gardless of the season. In the observed group of women,
20.3% had a 25 (OH) D deficiency.(is study also evidenced
that women over 80 years old and who lived alone were more
predisposed to a decrease in serum vitamin D.
An analysis of Australian citizens estimated that 31% had
vitamin D deficiency and linked this deficiency to increasing
age, female gender, obesity, and physical inactivity [28]. A
37.3% prevalence of vitamin D deficiency was also noted in
the Mexican population over 60 years [29].
Another critical factor is the skin color of the study
participants; despite not having found an association, the
group that presented hypovitaminosis D was composed of
34.8% white, 47.0% brown, and 13.6% black.
However, other studies show that skin color was related to
hypovitaminosis D. Lutsey et al. [30] analyzed 12,215 partici-
pants, of which 56% were women with an average age of 57.










N % N % N % N %
Obese/overweight 22 75.9 29 90.6 0.170 30 88.2 24 88.9 0.999
Not obese 7 24.1 3 9.4 4 11.8 3 11.1
NA: not applicable; Fisher’s exact test.










N % N % N % N %
Arterial hypertension
Yes 24 77.4 26 76.5 0.920a 27 77.1 23 82.1 0.624a
No 7 22.6 8 23.5 8 22.9 5 17.9
Diabetes mellitus
Yes 16 51.6 15 44.1 0.543a 18 51.4 20 71.4 0.107a
No 15 48.4 19 55.9 17 48.6 8 28.6
Fibromyalgia
Yes 2 6.5 1 2.9 0.602b 0 0 0 0 NA
No 29 93.5 33 97.1 35 100 28 100
Inflammatory diseases
Yes 5 16.1 5 14.7 0.999b 5 14.3 1 3.6 0.214b
No 26 83.9 29 85.3 30 85.7 27 96.4
NA: not applicable; a: chi-square test; b: Fisher’s exact test.
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(is study also associated ethnicity and race with 25(OH)D
serum levels, as black participants had an average of 18.2ng/mL,
and white participants had an average of 25.6ng/mL.(e lower
vitaminD cutaneous production in peoplewith black skin could
explain this hypovitaminosis D. Hypovitaminosis D also cor-
related, in this study, with younger ages, gender (female), ac-
tivities practiced, and obesity.
Another study also noted a higher prevalence of low 25
(OH) D concentration in black participants [31]. Melamed
et al. [32] showed that non-Hispanic blacks are more likely
to have vitamin D deficiency.
Regarding preexisting pathologies, there was no signif-
icant difference between the groups with low vitamin D
concentration and the control group. Nonetheless, in the
literature, an association between hypertension and vitamin
D deficiency has been described. Vimaleswaran et al. [33]
conducted a Mendelian randomization study that showed
that an increase in vitamin D concentration reduces the risk
of hypertension. Furthermore, the study of Kienreich et al.
[34] reinforces the theory that hypovitaminosis D is a risk
factor for hypertension. On the other hand, Gao et al. [35]
conducted a longitudinal study and found that low 25 (OH)
D levels were associated with the risk of the onset of pre-
diabetes and type 2 diabetes in the Chinese population.
(e present study investigated the distribution of the
VDR gene TaqI polymorphism in older women with
hypovitaminosis D (case group) compared to those with
vitamin D sufficiency (control group). However, no statis-
tically significant difference was found when the
polymorphism genotype and allele frequency were analyzed
with regard to low 25 (OH) D serum concentrations.
(e literature has shown correlations of these poly-
morphisms with several pathologies, such as osteoporosis,
risk of fractures, diabetes, metabolic syndrome, Alzheimer’s
disease, asthma, multiple sclerosis, susceptibility to tuber-
culosis, and cancer [12, 24, 36–42]. (e present study an-
alyzed the presence of specific pathologies with the TaqI
polymorphism frequency. (e mutated genotype (Tt + tt)
had a slightly higher frequency of hypertension (82.1%) and
diabetes (71.4%) in the control group, whereas, in the an-
cestral genotype (TT), hypertensive (77.4%) and diabetic
(51.6%) frequencies were higher in the case group. Never-
theless, no statistical difference was found between these
pathologies and TaqI polymorphism.
A case-control study conducted in obese Egyptian
women showed that the carriers of the VDR gene poly-
morphic alleles, ApaI (Aa +AA), FokI (Ff + ff), and TaqI
(Tt + tt), had significantly lower vitamin D serum values than
those with the ancestral genotype [37].
Selvaraj et al. [43] observed that the presence of poly-
morphisms could influence vitamin D receptor presence.
(e study noted that, with TaqI polymorphism, there is a
tendency for higher receptor levels in patients with ancestral
genotype (TT) in comparison with those that presented the
mutant allele (Tt + tt).
Nogueira et al. [44], in Brazil, showed, with regard to the
VDR gene TaqI polymorphism, a frequency of 51.25% of the
ancestral genotype (TT) in burn patients, but no association




N Mean SD Min Max N Mean SD Min Max
Glucose 31 125.4 60.9 56 322 34 107.8 41.4 62 243 0.175
HbA1c 31 6.6 1.6 4.7 10.8 34 6 1.2 4.6 9.5 0.090
Cholesterol 31 184.9 42.4 89 294.7 34 211.7 41.4 120 307 0.012
Triglycerides 31 138.1 62.6 52 270 34 168.5 79.9 62 441 0.095
HDL 31 48.2 13.2 23 85 34 48.1 6.7 36 60.3 0.969
LDL 31 110.5 39.7 35 210 34 130.5 40.6 33 234 0.049∗
AST 31 24.9 9.3 10 57 34 28.5 17.5 16 101 0.326
ALT 31 20.3 7.4 9 40 34 31.4 35.2 10 198 0.092
Creatinine 31 0.8 0.2 0.4 1.3 34 0.8 0.2 0.4 1.1 0.999




N Mean DP Min Max N Mean DP Min Max
Glucose 35 122.3 59.5 72 362 28 125 44.9 77 264 0.843
HbA1c 35 6.6 1.8 5.1 12.5 28 6.4 1.2 4.6 10 0.616
Cholesterol 35 200.5 47.3 121.1 281 28 198.2 49.8 127 351.4 0.852
Triglycerides 35 158.9 80.6 60 389 28 141.4 53.3 70 295 0.327
HDL 35 47.3 9 32.4 69.7 28 51.7 7.9 40 73.4 0.046∗
LDL 35 121.4 45.1 39 215 28 117 45.8 53 247 0.704
AST 35 25.5 10.9 9 59 36 24.9 8.6 13 46 0.797
ALT 35 26.5 13 9 63 36 22.4 9 11 54 0.126
Creatinine 35 0.7 0.2 0.4 1.3 36 0.8 0.2 0.5 1.3 0.039∗
Urea 35 30.7 12.6 10 60 36 35.1 13.4 11 76.2 0.159
Chi-square test; ∗p< 0.05.
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was found with hospital mortality. Carvalho et al. [45] found
73.1% of the heterozygous (Tt) genotype in older women,
and, likewise, no association with osteoporosis was detected.
Borges et al. [46] analyzed patients with chronic peri-
odontitis and had a frequency of 60% heterozygous genotype
(Tt) and 53.3% ancestral homozygous (TT).
Associations between biochemical parameters and vi-
tamin D serum levels have been established. Some studies
have shown that increased biomarker levels are associated
with hypovitaminosis D, such as creatinine and uric acid
[32, 47]. Nonetheless, in this study, no relationship was
observed between all the biochemical variables analyzed and
the 25(OH)D dosage, in quantitative terms. Although there
was an association between the aspartate transaminase
(AST) mean dosage and hypovitaminosis D, when evalu-
ating this hepatic marker’s altered and normal value, there
was no correlation. One study evaluated these parameters in
primary biliary cirrhosis and found that the increase in
transaminases, ASTand ALT, is correlated with low vitamin
D levels [43]. De Paula Scalioni et al. [48] demonstrated in
their study that people with high AST and cholesterol levels
are more prone to low circulating vitamin D.
5. Conclusion
(is study verified the nonassociation between vitamin D
serum levels and the VDR gene variant, TaqI polymorphism,
in an elderly Brazilian population. It also examined whether
the mutated genotype (Tt + tt) could affect vitamin D serum
concentration. However, no statistical difference was de-
tected between the polymorphism studied and vitamin D
level.
It is important to emphasize that this study did not
evaluate vitamin D receptor protein and other polymor-
phisms found in the VDR gene, such as BsmI and ApaI, as it
is not the focus of the study. Hence, future researches should
contemplate these aspects.
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